These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32256814)

  • 1. High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma.
    Song SS; Ying JF; Zhang YN; Pan HY; He XL; Hu ZM; Wang HJ; Dou XB; Mou XZ
    Oncol Lett; 2020 Apr; 19(4):3181-3188. PubMed ID: 32256814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis.
    Fondevila F; Fernández-Palanca P; Méndez-Blanco C; Payo-Serafín T; Lozano E; Marin JJG; González-Gallego J; Mauriz JL
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations of Foxo3 and Foxo4 expressions with clinicopathological features and prognosis of bladder cancer.
    Wang Y; Kang XL; Zeng FC; Xu CJ; Zhou JQ; Luo DN
    Pathol Res Pract; 2017 Jul; 213(7):766-772. PubMed ID: 28554751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
    Chen ZY; Wang T; Gan X; Chen SH; He YT; Wang YQ; Zhang KH
    Oncol Lett; 2020 Jun; 19(6):3889-3898. PubMed ID: 32382336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma.
    Xu Y; Sun C; Han B; Xi Y; Zhang M; Yang J; Chen Z
    Oncol Lett; 2020 Jul; 20(1):509-516. PubMed ID: 32565976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma.
    Zhang Y; Zhang S; Wang X; Liu J; Yang L; He S; Chen L; Huang J
    J Clin Pathol; 2012 Jun; 65(6):528-33. PubMed ID: 22422806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma.
    Li Q; Xiong DL; Wang H; Jin WL; Ma YY; Fan XM
    Onco Targets Ther; 2021; 14():2975-2988. PubMed ID: 33981147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of PTH1R is a poor prognosis in hepatocellular carcinoma.
    Wang HJ; Wang L; Song SS; He XL; Pan HY; Hu ZM; Mou XZ
    Cancer Biomark; 2018 Feb; 21(3):723-730. PubMed ID: 29278884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of expression of Myc-induced nuclear antigen 53 in hepatocellular carcinoma and its relationship with patient prognosis].
    Ye DX; Zhou X; Yang Q; Hu XY; Li H; Xiang FG
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):259-265. PubMed ID: 32306660
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
    Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
    BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
    Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
    Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma.
    Wang R; Yu Z; Chen F; Liao C; Wang Q; Huang X
    Hum Pathol; 2018 Mar; 73():114-121. PubMed ID: 29288040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Rho Guanine Nucleotide Exchange Factor 39 (ARHGEF39) and Its Prognostic Significance in Hepatocellular Carcinoma.
    Gao J; Jia WD
    Med Sci Monit; 2019 Oct; 25():7826-7835. PubMed ID: 31626606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low
    Cheng Y; Xing SG; Jia WD; Huang M; Bian NN
    Onco Targets Ther; 2017; 10():47-54. PubMed ID: 28031722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low expression of citron kinase is associated with poor patient outcomes in hepatocellular carcinoma.
    Zhang HQ; Wang HJ; He XL; Ru GQ; Song SS; Pan HY; Zhang CW; Mou XZ; Hu ZM
    Transl Cancer Res; 2020 Apr; 9(4):2416-2423. PubMed ID: 35117601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
    Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
    BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin4Rα (IL4Rα) and IL13Rα1 Are Associated with the Progress of Renal Cell Carcinoma through Janus Kinase 2 (JAK2)/Forkhead Box O3 (FOXO3) Pathways.
    Kang MA; Lee J; Ha SH; Lee CM; Kim KM; Jang KY; Park SH
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.